Lexapro and allergy medication is a common combination query, particularly as escitalopram (known as Cipralex in the UK) is widely prescribed for depression and anxiety, whilst antihistamines and other allergy treatments are frequently purchased over the counter. Understanding how these medicines interact is essential for safe, effective management of both conditions. Some allergy medications are entirely compatible with escitalopram, whilst others carry meaningful risks — including additive sedation, anticholinergic effects, and QT interval prolongation. This article explains the key interactions, highlights which allergy treatments are preferred, and advises when to seek guidance from a GP or pharmacist.

How Escitalopram (Cipralex) Works in the Body

Escitalopram, marketed under the brand name Lexapro in some countries and prescribed in the UK as Cipralex, is a selective serotonin reuptake inhibitor (SSRI). It works by blocking the reabsorption (reuptake) of serotonin in the brain, increasing the availability of this neurotransmitter in the synaptic cleft. This mechanism helps regulate mood, anxiety, and emotional responses.

SSRIs are recommended as first-line pharmacological treatment for depression and generalised anxiety disorder (GAD) in adults, in line with NICE guidelines (NG222 and CG113). Sertraline is commonly recommended first for GAD; escitalopram is an established SSRI option that may be selected based on individual clinical circumstances and prescriber judgement.

Escitalopram is metabolised primarily in the liver via cytochrome P450 enzymes. The primary pathway is CYP2C19, with additional contributions from CYP2D6 and CYP3A4. This is clinically important because medicines that inhibit CYP2C19 — such as omeprazole, esomeprazole, and cimetidine — can increase escitalopram plasma concentrations, potentially raising the risk of side effects including QT interval prolongation.

Experiencing these side effects? Our pharmacists can help you navigate them →

Common side effects of escitalopram include:

• Nausea and gastrointestinal upset, particularly in the first few weeks

• Headaches and dizziness

• Insomnia or drowsiness

• Dry mouth and increased sweating

• Sexual dysfunction (including reduced libido and delayed orgasm), which is very common with SSRIs and may persist

• Hyponatraemia (low sodium), particularly in older adults — symptoms include confusion, weakness, and oedema

Most side effects are mild and tend to resolve as the body adjusts to the medication. Patients should not stop escitalopram suddenly without medical advice, as this can cause discontinuation symptoms. Because escitalopram affects serotonin pathways and liver metabolism, it is important to consider how it may interact with other commonly used medicines, including those taken for allergies.

If you experience a suspected side effect from escitalopram or any other medicine, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Common Allergy Medications Available in the UK

In the UK, allergy medications are widely available both over the counter (OTC) and on prescription. They are broadly categorised into antihistamines, corticosteroids, decongestants, and leukotriene receptor antagonists, each targeting different aspects of the allergic response.

Antihistamines are the most commonly used and are divided into two generations:

• First-generation antihistamines (e.g., chlorphenamine, promethazine) — these cross the blood-brain barrier and can cause significant sedation and anticholinergic effects. They are available OTC (e.g., chlorphenamine as Piriton).

• Second-generation antihistamines (e.g., cetirizine, loratadine, fexofenadine) — these are non-sedating or minimally sedating and are generally preferred for daytime use. Cetirizine and loratadine are widely available OTC. Fexofenadine 120 mg is available OTC for hay fever; the 180 mg strength may require a prescription.

Nasal corticosteroid sprays such as beclometasone and fluticasone are recommended by NICE for moderate-to-severe allergic rhinitis and carry a low risk of systemic interactions due to minimal absorption into the bloodstream.

Decongestants such as pseudoephedrine (oral) and xylometazoline (topical nasal spray) are used for nasal congestion. Oral decongestants carry a significant interaction risk with monoamine oxidase inhibitors (MAOIs) and should be avoided in patients taking them; they are not contraindicated with SSRIs such as escitalopram, but may exacerbate anxiety, insomnia, or raise blood pressure and heart rate in sensitive individuals. Topical nasal decongestants such as xylometazoline should be limited to a maximum of seven days to avoid rebound congestion (rhinitis medicamentosa).

Not sure if this is normal? Chat with one of our pharmacists →

Montelukast, a leukotriene receptor antagonist available on prescription, is sometimes used for allergic rhinitis and asthma. The MHRA has issued a safety update highlighting the risk of neuropsychiatric reactions with montelukast, including sleep disturbances, mood changes, and suicidal thoughts. Patients and carers should seek medical advice promptly if such symptoms occur.

Understanding which category of allergy medication you are using is essential when taking escitalopram, as the interaction risk varies considerably between these drug classes.

Interactions Between Escitalopram and Antihistamines

The interaction profile between escitalopram and allergy medications depends largely on the specific antihistamine or allergy treatment being used. For the majority of second-generation antihistamines — such as cetirizine, loratadine, and fexofenadine — there is no clinically significant pharmacokinetic interaction with escitalopram. These medications are generally considered safe to use alongside SSRIs when taken at recommended doses, and they are often the preferred choice for people managing allergies whilst on antidepressant therapy.

However, first-generation antihistamines such as chlorphenamine and promethazine present a more complex picture. These older antihistamines have anticholinergic properties and central nervous system (CNS) depressant effects. When combined with escitalopram, there is a potential for:

• Additive sedation, which can impair concentration, coordination, and the ability to drive safely

• Increased anticholinergic burden, potentially causing dry mouth, urinary retention, blurred vision, and constipation

The primary concerns with first-generation antihistamines are sedation and anticholinergic effects rather than QT prolongation at usual therapeutic doses.

QT interval prolongation is a more specific concern with certain antihistamines. Hydroxyzine (prescribed for anxiety, urticaria, or pruritus) and mizolastine carry a recognised risk of QT prolongation, as highlighted in a 2015 MHRA Drug Safety Update on hydroxyzine. Combining either of these with escitalopram — which itself carries a dose-dependent QT prolongation risk — should be avoided where possible, or only undertaken with clear clinical justification and appropriate monitoring. If such a combination is considered necessary, a baseline ECG and assessment of electrolytes should be discussed with the prescribing clinician.

Patients should be aware that CYP2C19 inhibitors (such as omeprazole, esomeprazole, or cimetidine), if taken concurrently, can raise escitalopram plasma levels and further increase QT risk.

The MHRA and the electronic Medicines Compendium (eMC) advise caution when combining escitalopram with other CNS-active agents. Patients should always disclose all medications — including OTC products — to their prescriber or pharmacist.

Risks and Side Effects to Be Aware Of

When taking escitalopram alongside allergy medications, there are several potential risks that patients and healthcare professionals should be mindful of.

Additive sedation is the most commonly encountered concern, particularly when first-generation antihistamines are used. This can affect daily functioning, including the ability to drive or operate machinery safely. UK law requires drivers not to drive if impaired by medication; patients should follow NHS guidance on medicines and driving.

QT interval prolongation is a more serious but less common concern. Escitalopram carries a known dose-dependent risk of prolonging the QT interval, which can predispose individuals to arrhythmias. The MHRA has issued specific guidance on this risk, including the following dose limits:

• Maximum 20 mg per day in adults

• Maximum 10 mg per day in older adults and those with hepatic impairment

Hydroxyzine is also subject to MHRA dose restrictions (maximum 100 mg per day in adults; avoid in older adults where possible). Combining hydroxyzine or mizolastine with escitalopram should be avoided or approached with great caution. Risk is further increased in patients with:

• Pre-existing cardiac conditions

• Electrolyte imbalances (e.g., low potassium or magnesium)

• A personal or family history of long QT syndrome

• Concurrent use of CYP2C19 inhibitors (e.g., omeprazole, esomeprazole, cimetidine), which can raise escitalopram levels

Where a combination of QT-prolonging medicines is clinically necessary, a baseline ECG and electrolyte check should be considered.

Serotonin syndrome is a rare but potentially serious condition caused by excessive serotonergic activity. Standard antihistamines are not serotonergic and do not typically contribute to this risk. The risk arises when escitalopram is combined with other serotonergic agents such as MAOIs, linezolid, triptans, or tramadol. Symptoms include agitation, confusion, rapid heart rate, high temperature, and muscle twitching. Patients should be vigilant if they are taking multiple medications that influence serotonin.

Anticholinergic side effects from first-generation antihistamines may be amplified in individuals already experiencing dry mouth or constipation as a result of escitalopram. Monitoring for these overlapping effects is advisable, particularly in older adults who may be more sensitive to anticholinergic burden.

When to Seek Advice from a GP or Pharmacist

Patients taking escitalopram should always consult a GP or pharmacist before starting any new allergy medication, even if it is available without a prescription. OTC products can carry meaningful interaction risks when combined with prescription antidepressants.

Call 999 or go to your nearest A&E immediately if you experience:

• Chest pain, collapse, or fainting

• Severe or rapid palpitations

• Seizures

• High fever with agitation, confusion, muscle rigidity, or twitching (possible features of serotonin syndrome)

Contact your GP or call NHS 111 promptly if you experience:

• Unusual or excessive drowsiness that interferes with daily activities

• Heart palpitations or irregular heartbeat not severe enough to require emergency care

• Confusion or unusual changes in mood or behaviour

• Difficulty passing urine, severe dry mouth, or blurred vision

• Any new or worsening symptoms that concern you

Do not stop taking escitalopram suddenly without medical advice, as this can cause discontinuation symptoms such as dizziness, nausea, and flu-like feelings. Always speak to your prescriber before making any changes to your dose.

Your community pharmacist is an excellent first point of contact if you are unsure whether a particular allergy product is safe to take with escitalopram. Pharmacists are trained to identify drug interactions and can advise on suitable alternatives without the need for a GP appointment.

If you are pregnant, breastfeeding, elderly, or managing other long-term conditions, exercise additional caution and always seek professional advice before combining medications. If your allergy symptoms are persistent or worsening, inform your prescriber, as a more structured allergy management plan may be appropriate.

Suspected side effects from any medicine can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Managing Allergies Safely Whilst Taking Escitalopram

For most people taking escitalopram, managing seasonal or perennial allergies safely is entirely achievable with the right approach. The key is selecting allergy treatments with a low interaction risk and using them at recommended doses under appropriate guidance.

Preferred options for allergy management alongside escitalopram include:

• Second-generation antihistamines such as cetirizine, loratadine, or fexofenadine 120 mg — these are non-sedating, widely available OTC, and have a favourable interaction profile with SSRIs. They are the preferred antihistamine choice for people taking escitalopram.

• Intranasal corticosteroid sprays such as fluticasone or beclometasone — highly effective for allergic rhinitis and with negligible systemic absorption, making them a safe choice.

• Sodium cromoglicate eye drops for allergic conjunctivitis — these act locally and have no known systemic interactions.

Antihistamines to use with caution or avoid:

• Hydroxyzine and mizolastine should be avoided where possible in patients taking escitalopram due to the combined QT prolongation risk. If clinically necessary, use the lowest effective dose, adhere to MHRA dose limits, and discuss ECG and electrolyte monitoring with your prescriber.

• First-generation antihistamines (chlorphenamine, promethazine) should be used with caution due to additive sedation and anticholinergic effects; second-generation alternatives are preferred.

If using topical nasal decongestants (e.g., xylometazoline), limit use to a maximum of seven days to prevent rebound nasal congestion.

Non-pharmacological strategies can also play an important role in reducing reliance on allergy medications:

• Monitoring pollen counts and limiting outdoor exposure on high-pollen days

• Using allergen-proof bedding covers for dust mite allergy

• Keeping windows closed during peak pollen season

• Showering after outdoor activities to remove pollen from hair and skin

If allergy symptoms are significantly impacting quality of life despite optimal medical treatment, a GP referral to an NHS allergy clinic may be appropriate. Allergen immunotherapy (desensitisation) is available on the NHS for selected patients with confirmed IgE-mediated allergy who have not achieved adequate control with standard therapy, and can provide long-term relief without the need for ongoing medication.

In summary, whilst there is no blanket contraindication between escitalopram and all allergy medications, informed choices — guided by a pharmacist or GP — are essential to ensure both conditions are managed safely and effectively.

Frequently Asked Questions